Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 manufacturing. To overcome hurdles in global vaccination efforts, biopharmaceutical companies have established partnerships to help support increased manufacturing output and speed up the ability to fight COVID-19 as distribution capacity is expanded around the globe.